OptimOva is a patented blood test method developed at Oslo University Hospital. The test personalises hormone dosing by fine-tuning the routine dosing standard and adjusting the prescribed dose to the patient’s needs. The objective of this novel test is to optimise egg production, thus increasing the chances for having enough good quality embryos and ultimately improving chances for pregnancy and live birth delivery. In addition, excess good quality embryos are cryopreserved for future cycles, eliminating the need for further hormonal treatment.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Oslo, No
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- ivffit.com
- Keywords
- Personalize medicine, Infertility, In vitro fertilisation, Medical diagnostics, Heathcare, Startup, Medical science.
- HQ
- Oslo
Ivf Fit As Questions
Ivf Fit As's website is ivffit.com
Ivf Fit As's LinkedIn profile is https://no.linkedin.com/company/ivffit
Ivf Fit As has
3 employees.
View email and phone details for 3
employees at Ivf Fit As.
Ivf Fit As's industry is
Medical Equipment Manufacturing
Ivf Fit As's top competitors are
Ivf Doctorsapp,
Ivf Plus Healthcare Consulting Company,
Artlab Ivf Training And Research Center,
Ivf Assistants,
Proov,
Central Ivf Meds,
Aspivix,
Ivf Brazil,
Ivf North East® Ltd.,
Ivf Network Ltd..
Ivf Fit As's categories are Medical Equipment Manufacturing
Ivf Fit As's founding year is 2018
